The endocannabinoid system drives neural progenitor proliferation

被引:253
作者
Aguado, T
Monory, K
Palazuelos, J
Stella, N
Cravatt, B
Lutz, B
Marsicano, G
Kokaia, Z
Guzmán, M
Galve-Roperh, I [1 ]
机构
[1] Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain
[2] Max Planck Inst Psychiat, D-80804 Munich, Germany
[3] Univ Washington, Seattle, WA 98195 USA
[4] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[5] Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[6] Univ Lund Hosp, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lab Neurol Stem Cell Biol, SE-22184 Lund, Sweden
关键词
cannabinoid; CB1; receptor; NP;
D O I
10.1096/fj.05-3995fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The discovery of multipotent neural progenitor (NP) cells has provided strong support for the existence of neurogenesis in the adult brain. However, the signals controlling NP proliferation remain elusive. Endocannabinoids, the endogenous counterparts of marijuana-derived cannabinoids, act as neuromodulators via presynaptic CB1 receptors and also control neural cell death and survival. Here we show that progenitor cells express a functional endocannabinoid system that actively regulates cell proliferation both in vitro and in vivo. Specifically, NPs produce endocannabinoids and express the CB1 receptor and the endocannabinoid-inactivating enzyme fatty acid amide hydrolase ( FAAH). CB1 receptor activation promotes cell proliferation and neurosphere generation, an action that is abrogated in CB1-deficient NPs. Accordingly, proliferation of hippocampal NPs is increased in FAAH-deficient mice. Our results demonstrate that endocannabinoids constitute a new group of signaling cues that regulate NP proliferation and thus open novel therapeutic avenues for manipulation of NP cell fate in the adult brain.
引用
收藏
页码:1704 / +
页数:14
相关论文
共 33 条
[1]   For the long run: Maintaining germinal niches in the adult brain [J].
Alvarez-Buylla, A ;
Lim, DA .
NEURON, 2004, 41 (05) :683-686
[2]   The "dark side" of endocannabinoids: A neurotoxic role for anandamide [J].
Cernak, I ;
Vink, R ;
Natale, J ;
Stoica, B ;
Lea, PM ;
Movsesyan, V ;
Ahmed, F ;
Knoblach, SM ;
Fricke, ST ;
Faden, AI .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2004, 24 (05) :564-578
[3]   Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase [J].
Cravatt, BF ;
Demarest, K ;
Patricelli, MP ;
Bracey, MH ;
Giang, DK ;
Martin, BR ;
Lichtman, AH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9371-9376
[4]   Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway [J].
del Pulgar, TG ;
de Ceballos, ML ;
Guzmán, M ;
Velasco, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :36527-36533
[5]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[6]   The endogenous cannabinoid system and brain development [J].
Fernández-Ruiz, J ;
Berrendero, F ;
Hernáandez, ML ;
Ramos, JA .
TRENDS IN NEUROSCIENCES, 2000, 23 (01) :14-20
[7]   Anti-tumoral action of cannabinoids:: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation [J].
Galve-Roperh, I ;
Sánchez, C ;
Cortés, ML ;
del Pulgar, TG ;
Izquierdo, M ;
Guzmán, M .
NATURE MEDICINE, 2000, 6 (03) :313-319
[8]   Cannabinoids:: Potential anticancer agents [J].
Guzmán, M .
NATURE REVIEWS CANCER, 2003, 3 (10) :745-755
[9]   Cannabinoids induce cancer cell proliferation via tumor necrosis factor α-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor [J].
Hart, S ;
Fischer, OM ;
Ullrich, A .
CANCER RESEARCH, 2004, 64 (06) :1943-1950
[10]   Cannabinoid physiology and pharmacology: 30 years of progress [J].
Howlett, AC ;
Breivogel, CS ;
Childers, SR ;
Deadwyler, SA ;
Hampson, RE ;
Porrino, LJ .
NEUROPHARMACOLOGY, 2004, 47 :345-358